Reduced expression of SMN protein in SMA leads to impaired α-motor neuron development and degeneration, manifesting as skeletal muscle weakness, the most evident clinical manifestation of SMA [26]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.